SMi reports: Exclusive Chair letter invite released for Pre-Filled Syringes West Coast 2020 SMi Group’s 5th annual Pre-Filled Syringes West Coast conference is set to return on the 15th – 16th June in San Diego, […]
The European Commission (EC) has approved Alnylam’s Givlaari (givosiran) for adults and adolescents with acute hepatic porphyria (AHP). Givlaari was previously granted priority medicines designation by the European Medicines Agency, as well as orphan designation […]
Eli Lilly has announced that the company is not expecting coronavirus-related drug shortages, including all forms of insulin. The company does not source active pharmaceutical ingredients from China for any of its approved drugs. Also, […]
Gilead Sciences has commenced two Phase III clinical trials of its investigational antiviral drug, remdesivir, for the treatment of Covid-19 in adults. This announcement comes after the US Food and Drug Administration (FDA) accepted and […]
Iktos, a French artificial intelligence (AI) start-up company, has joined forces with California-based research institute SRI International to accelerate discovery and development of therapies for the Wuhan coronavirus (COVID-19) and other viruses. As part of […]